Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$98.44
pos +0.00
+0.00%
Today's Range: 98.32 - 99.02 | JNJ Avg Daily Volume: 7,630,000
Last Update: 07/02/15 - 4:01 PM EDT
Volume: 0
YTD Performance: -5.86%
Open: $0.00
Previous Close: $98.47
52 Week Range: $95.10 - $109.49
Oustanding Shares: 2,773,045,351
Market Cap: 272,978,584,352
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 2 2 2 3
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.07 2.07 2.07 2.06
Latest Dividend: 0.75
Latest Dividend Yield: 3.05%
Dividend Ex-Date: 05/21/15
Price Earnings Ratio: 17.61
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
17.61 17.60 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.20% -7.01% 44.76%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.20 0.14 0.05
Net Income 18.00 0.69 0.19
EPS 18.60 0.64 0.18
Earnings for JNJ:
EBITDA 24.85B
Revenue 74.33B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.71 $1.43 $6.14 $6.43
Number of Analysts 10 9 13 13
High Estimate $1.87 $1.57 $6.24 $6.60
Low Estimate $1.58 $1.25 $6.08 $6.21
Prior Year $1.66 $1.50 $5.97 $6.14
Growth Rate (Year over Year) 3.25% -4.44% 2.82% 4.74%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It's likely to meander sideways for about a year.
As health-care stocks rally, it's time for politicians to move on.
Don't rely on Europe; it's too out of sync with U.S.
Jim Cramer recently shared his insight on some of the best potential takeover targets, and we're taking his lead and looking at how his picks stack up from a technical analysis standpoint.
All would produce higher prices for the acquirers.
Focus on companies that benefit from an improving economy.
Greece and oil are positives, but employment was too strong.
The dollar is weakening. That's actually good for stocks. 
Picking up some high yielders might be worthwhile.

Columnist Conversations

Last week, before the referendum, the turmoil in Greece was seen as an opportunity to buy the dip, according t...
The Chinese authorities implemented pretty radical measures over the weekend to stem the massive declines in t...
Global markets hit hard as the Greeks voted in majority against further austerity measures setting up a showdo...
The actions taken by various political entities and vocalizations of them by individual representatives of Gre...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.